Logo.jpg
Biofrontera AG reports completion of the clinical phase of the pharmacokinetics study
October 08, 2020 11:04 ET | Biofrontera AG
Leverkusen, Germany, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, reports the...
Logo.jpg
Biofrontera AG: German Federal Supreme Court overturns ruling of the Cologne Higher Regional Court
September 22, 2020 12:02 ET | Biofrontera AG
Leverkusen, Germany, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that in...
Logo.jpg
Biofrontera AG plans mediation to resolve (legal) disputes
September 11, 2020 07:33 ET | Biofrontera AG
Leverkusen, Germany, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
Logo.jpg
Biofrontera AG to participate in two upcoming conferences
September 09, 2020 08:00 ET | Biofrontera AG
Leverkusen, Germany, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...
Logo.jpg
Biofrontera report results for the first six months of 2020
August 26, 2020 09:51 ET | Biofrontera AG
Leverkusen, Germany, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today published its...
Logo.jpg
Biofrontera announces conference call to be held on August 27, 2020 to discuss half-year 2020 financial results
August 19, 2020 04:30 ET | Biofrontera AG
Leverkusen, Germany, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Logo.jpg
Biofrontera AG resolves to issue qualified subordinated mandatory convertible bonds
July 27, 2020 13:15 ET | Biofrontera AG
Leverkusen, Germany, July 27, 2020 (GLOBE NEWSWIRE) -- The Management Board of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today resolved, with the approval of the Supervisory...
Logo.jpg
Supervisory Board of Biofrontera AG renews Management Board appointment
July 23, 2020 08:30 ET | Biofrontera AG
Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today...
logo.jpg
Biofrontera reports preliminary unaudited sales revenue for the first six months of 2020
July 14, 2020 06:08 ET | Biofrontera AG
Leverkusen, Germany, July 14, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
logo.jpg
Biofrontera confirms financing need
June 30, 2020 08:30 ET | Biofrontera AG
Leverkusen, Germany, June 30, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today confirmed the...